| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |